ARTICLE | Clinical News
Ozarelix: Phase I started
August 1, 2005 7:00 AM UTC
The partners began a U.S. Phase I trial in patients. The compound is in 2 European Phase II trials for hormone-dependent prostate cancer and benign prostate hypertrophy. ...